MedTech World

22/08/2025

🌍 Innovation isn’t confined to one region.

At MedTech World Bay Area 2025, Chrish Japp, Partner at Tramway Venture Partners , shared how:
✅ An AI-powered hospital in China is redefining healthcare delivery
✅ Global South’s unmet needs are sparking leapfrog innovations
✅ The tech landscape is shifting beyond traditional Western models

🎥 Watch the full panel video on our YouTube channel
👉🏻 https://eu1.hubs.ly/H0mvGjb0

This November, conversations like this return to MedTech Malta 2025.
📅 12–14 Nov 2025 | Valletta, Malta
🎟️ Secure your ticket today: https://eu1.hubs.ly/H0mvG570

22/08/2025

Tenon Medical, Inc. redefines sacro-pelvic fusion with SiVantage acquisition

Tenon Medical has taken a transformative step forward with the acquisition of SiVantage Technologies, adding groundbreaking solutions like SImmetry and SImmetry+ to its portfolio. This move expands Tenon’s innovation roadmap, strengthens its SI joint fusion offering, and accelerates its physician-focused strategy.

🔑 Key Highlights:
• Integration of SImmetry & SImmetry+, advancing authentic sacro-pelvic fusion
• Physician-driven innovation pipeline with multiple anatomical approaches
• Launch of new sacro-pelvic technologies planned within 12–24 months
• Hybrid commercialization model combining direct sales + distributors
• Strong leadership additions: Wyatt Geist, Chief Innovations Officer & Nate G., Chief Commercial Officer

CEO Steven M. Foster describes the acquisition as “transformative for Tenon Medical in the areas of Products, Pipeline and People.”

Read More: https://med-tech.world/news/tenon-medical-sivantage-acquisition/

📅 Want more MedTech insights like this? Join us at MedTech Malta 2025 (12–14 Nov)
👉🏻 https://tickets.med-tech.world/medtech-malta-2025

Tenon Medical expands its sacro-pelvic fusion portfolio with the acquisition of SiVantage, bringing SImmetry and SImmetry+ under its umbrella. Leaders share insights on innovation, authentic fusion, and a new commercial strategy set to redefine the SI joint fusion space.

21/08/2025

It was an absolute pleasure to welcome Prof. Natasha Azzopardi-Muscat, Director at World Health Organization (WHO)/Europe, to the MedTech World Podcast studios.

In this special episode, we journey with her from her beginnings in Malta to the global stage, where she now represents 53 countries in shaping stronger, purpose-driven health systems.

It’s a conversation filled with warmth, wisdom, and vision, one that reminds us why healthcare must always put people first. 🎙️✨

✨ Subscribe to our podcast and catch the episode as soon as it’s live:
🎧 Spotify: https://eu1.hubs.ly/H0mtR_d0
▶️ YouTube: https://eu1.hubs.ly/H0mtS6v0

21/08/2025

MedTech CEO Forum

💭 What happens when MedTech Startup CEOs meet behind closed doors?

This November, at , we’re creating a space where only MedTech CEOs gather for raw, peer-level dialogue, away from the spotlight, press, and pitches.

🔒 Invite-only. MedTech Startup CEO-exclusive. This is where leadership challenges, market shifts, and strategies for tomorrow’s landscape are discussed in confidence.

💬 If you had the chance, what’s one question you’d ask a MedTech Startup CEO? Drop it in the comments ⬇️

🗓️ 12–14 Nov 2025 | Valletta, Malta
🎟️ Secure your pass or upgrade today: https://eu1.hubs.ly/H0mtspZ0

21/08/2025

TA Ventures portfolio company Gameto secures $44M to advance fertility therapy

Gameto, a clinical-stage biotech in women’s health, has raised $44M in Series C funding, bringing total capital to $127M. 🚀

Its lead program, Fertilo—now in Phase 3—could transform IVF by cutting weeks of hormone injections to just 2–3 days. Already cleared in multiple countries, Fertilo has resulted in 20+ pregnancies and 5 births. 👶✨

🔑 Key Highlights:
• $44M Series C led by Overwater Ventures
• Total funding: $127M
• Fertilo: first iPSC-derived fertility therapy in late-stage US trials
• Cleared in Mexico, Peru, Australia & Japan
• Expanding pipeline into menopause therapies

With strong backing from top investors, Gameto is redefining fertility and women’s health innovation.

📖 Read full story: https://med-tech.world/news/gameto-secures-44m-to-advance-fertility-therapy

Gameto secures $44M in Series C funding to advance Fertilo, its fertility therapy in Phase 3 trials, and expand its women’s health pipeline.

20/08/2025

🚀 Startup of the Week | Auctus Surgical, Inc.

Welcome to Startup of the Week — our series spotlighting bold innovators tackling real-world health challenges.

This week, meet Auctus Surgical, a pioneering team developing a dynamic vertebral body tethering (VBT) system to treat pediatric scoliosis.

Unlike traditional spinal fusion, their adjustable, non-fusion approach allows gradual, non-surgical adjustments over time — reducing risks, preventing overcorrection, and acting as an internal brace. The goal? More mobility, fewer surgeries, and better quality of life for children.

💡 Real problems. Smart solutions.

📣 Are you a founder building breakthrough healthcare tech?
Pitch at our upcoming events and share your story with the world.
Register Now: https://eu1.hubs.ly/H0msbLf0

🗓️ MedTech World Singapore — 01 October
Pre-reg Now: https://eu1.hubs.ly/H0msgV00

🗓️ MedTech Malta — 12–14 November | Malta
Tickets: https://eu1.hubs.ly/H0msfFj0

the week

20/08/2025

🚀 “An A-team with a B idea beats a B-team with an A idea every day.”

What makes a startup truly investable?
✔️ A big enough market
✔️ A strong, visionary team
✔️ Solving real unmet needs

In this video, Tyler Wanke shares how MadSci spun out from the University of Wisconsin with clinical co-founders who were top neurosurgeons and neurologists—proving that the right mix of people, science, and vision creates both an A-team and an A-idea.

🎥 Watch the full video here: https://eu1.hubs.ly/H0msfDj0

✈️Up Next
MedTech Singapore | 1 Oct 2025
Tickets: https://eu1.hubs.ly/H0msdQR0

✈️Flagship Event
MedTech Malta 2025 | 12-14 Nov 2025 | Valletta, Malta
Tickets: https://eu1.hubs.ly/H0ms9Fk0

20/08/2025

❓ How do you build a MedTech startup that lasts—not just one that launches?

In our panel “From Regulatory to Revenue: Building with the End in Mind”, experts — Mridul Mittal, Co-founder & CMO, Mittal Consulting, Mariel Fabro, Managing Partner, Beacon Launch Partners, Christian Espinosa, Founder & CEO, Blue Goat Cyber, Gary Gershony, Founding General Partner BayMed Venture Partners, and Kristen Mittal, RAC, PMP, Co-founder & CEO, Mittal Consulting — shared lessons every founder needs.

They answered:
🔹 When should you bring in a product development firm?
🔹 How do you know if your device is a “cyber device” — and when to secure it?
🔹 What do investors really want to see in a pitch?
💡 Plus insights on regulatory pathways, reimbursement, and commercialization.

👉 Read the full recap here: https://med-tech.world/news/building-with-the-end-in-mind-what-every-medtech-startup-needs-to-know/

This November, more questions like this will be tackled at the heart of the Mediterranean.
📍 MedTech Malta 2025 | Nov 12–14 | Valletta, Malta
🎟️ Tickets: https://tickets.med-tech.world/medtech-malta-2025

Medtech startups face a unique challenge: how to bring complex, regulated products to market under tight timelines and even tighter budgets. Success isn’t just about breakthrough innovation—it’s about navigating product development, regulatory approval, cybersecurity, reimbursement, and invest...

19/08/2025

The MedTech Malta 2025 stage just got even more exciting 🎤✨

We’re welcoming a fresh lineup of trailblazers—founders, investors, innovators, and global health leaders, ready to share ideas that matter.

📅 12–14 Nov 2025 | Valletta, Malta
🎟️ Tickets: https://tickets.med-tech.world/medtech-malta-2025

🔖 Featuring:
Salih Oğuz Savaş | Ivanny Franklin | Kevin Saem, Ph.D.| Shaherah Yancy |
Professor Shafi Ahmed | George Gregory | Homer Quintana | Dame Clare Gerada Professor Gordon Wishart | Oliver Bisazza | Alex Diaconu | Soyoung Park | Pedro David Espinoza | Alexandra P. | Sahirzeeshan (Sahir) Ali | Jorgen Souness | Ing Karl Farrugia | Lee Fleisher | Julia Zarb | Prof. Yaron Ilan

19/08/2025

🕒 The earlier you book, the more you save.

📍 This November, Malta brings the MedTech world together for:
🎤 300+ expert speakers
🤝 100+ sponsors & partners
📊 1500+ high-impact meetings
🌍 2,000+ attendees worldwide
💼 20% investors & 35% MedTech companies

🎟️ Early Bird tickets are live — secure your spot before prices go up!

📅 12-14 Nov 2025 | Valletta, Malta
🔗 Book now: https://eu1.hubs.ly/H0mrczk0

19/08/2025

💬 “We must invest more in prevention, research, and mental health — the pillars of a stronger and more competitive Europe.”

In an exclusive interview with MedTech World, Hon. Michele Picaro, MEP European Conservatives and Reformists Group, highlights the urgent need to rebalance EU healthcare — putting prevention, innovation, and patient well-being at the center.

🔑 Key Points:
Shifting EU healthcare investment towards prevention
Supporting pharma innovation through extended patents
Harnessing telemedicine and 5G for accessible care
Promoting the Mediterranean diet as a prevention model
Expanding mental health support across Member States

🎥 Watch the full interview →https://www.youtube.com/watch?v=fUSZRNeQEW4&t=1s

📍 Want to be part of these conversations? Join us this November at MedTech Malta 2025, where global leaders, innovators, and policymakers come together to connect and collaborate. → https://eu1.hubs.ly/H0mqX5m0

🙏 A sincere thank you to MEP Michele Picaro for sharing his time and perspective with us.

19/08/2025

🩺 $2.25B Deal: HistoSonics Inc. . Joins Forces with Bezos-Backed Investors

HistoSonics, creator of the Edison® Histotripsy System, has been acquired in a management-led deal backed by K5 Global, Bezos Expeditions, Wellington Management, & more — fueling global scale and new cancer treatments.

💬 “Our focus has been speed, scale, and urgency to offer patients a better option,” said Mike Blue, President & CEO, HistoSonics

💬 “This is one of those rare moments where science, ex*****on, and opportunity all align,” added Bryan Baum, Co-Founder, K5 Global.

Key Highlights:
🔹 $2.25B acquisition with leadership team staying on
🔹 FDA-cleared tech destroys tumors without incisions or heat
🔹 Trials for kidney & pancreatic cancers underway
🔹 2,000+ patients treated, 50 new systems coming in 2025

📌 Read full story: https://med-tech.world/news/histosonics-acquired-in-2-25b-deal-backed-by-bezos-expeditions-k5-global-and-others/

📅 Meet MedTech innovators in Malta, 12–14 Nov 2025
🎟 Tickets: https://tickets.med-tech.world/medtech-malta-2025

HistoSonics, the company behind the Edison® Histotripsy System, has announced its acquisition in a management-led deal backed by a consortium of public and private investors. The $2.25 billion transaction, led by firms such as K5 Global, Bezos Expeditions, and Wellington Management, marks a major i...